Alerts will be sent to your verified email
Verify Email
PANACEABIO
|
Panacea Biotec
|
Indoco Remedies
|
Novartis
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
17.16 % | 8.94 % | 8.0 % |
|
5yr Avg Net Profit Margin
|
19.26 % | 5.41 % | 17.12 % |
|
Price to Book
|
3.06 | 2.41 | 2.94 |
|
P/E
|
222.38 | 0.0 | 22.42 |
|
5yr Avg Cash Conversion Cycle
|
-102.87 Days | 35.3 Days | -23.33 Days |
|
5yr Average Interest Coverage Ratio
|
2.9 | 7.53 | 65.43 |
|
5yr Avg ROCE
|
-1.68 % | 13.6 % | 5.91 % |
|
5yr Avg Operating Profit Margin
|
-1.99 % | 14.97 % | 15.15 % |
|
5 yr average Debt to Equity
|
0.05 | 0.49 | 0.0 |
|
5yr CAGR Net Profit
|
-64.03 % | n/a | 37.01 % |
|
5yr Average Return on Assets
|
6.95 % | 5.31 % | 3.13 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
72.48 % | 58.9 % | 70.68 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
-1.11 % | 0.21 % | 0.0 |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 1.16 % | 0.0 |
|
Panacea Biotec
|
Indoco Remedies
|
Novartis
|
|---|